Procter & Gamble is probably not the only consumer packaged goods company looking very closely at the dietary supplements sector right now given how much faster it is growing than mainstream grocery, according to the boss of Vitamin Shoppe.
Firms sourcing sucralose from China are struggling to secure supplies owing to a combination of factors including rising demand as sugar prices rise, electricity shortages in southern China and tighter enforcement of environmental legislation, FoodNavigator-USA...
Supply issues with some major manufacturers coupled with rising demand have sent the price of some amino acids through the roof, according to leading nutraceutical ingredients importer and supplier DNP International.
Nutronics Labs says a letter sent out by Major League Baseball (MLB) last year warning players to avoid deer antler velvet supplements has sullied its good reputation and caused “extensive and irreparable damage”.
Vitamin Shoppe boss Tony Truesdale would not say how much the FDA crackdown on DMAA is likely to cost the business after being repeatedly pressed by analysts on the issue during the firm’s first quarter earnings call.
While Procter & Gamble’s move into the dietary supplements market might have been unexpected, the fact it chose New Chapter as its entry vehicle should come as no surprise, according to one investor in the Vermont-based firm.
New Chapter will continue to run as a standalone business under new owner Procter & Gamble, but will get a "turbocharge" to its mission, according to bosses at the Vermont-based supplement firm.
PTeroPure maker ChromaDex has posted a 7% rise in revenues to $8.1m in the fiscal year ending December 31, 2011, but notched up a net loss of $7.9m compared with a net loss of $2.1m in 2010.
Utah-based direct selling supplements firm Nature's Sunshine Products (NSP) moved back into the black in the fourth quarter of 2011 posting a net profit on continuing operations of $7.6m vs a net loss of $0.4m a year ago.
Aker BioMarine has posted a 35% surge in sales of Superba krill oil in the fourth quarter of 2011 – selling a record 70 metric tons compared with 52t in Q4, 2010.
Illinois-based health food and supplements manufacturer NOW Foods is on course to complete its $20m new site in Nevada in the third quarter of this year, almost two years ahead of schedule.
PTeroPure maker ChromaDex is set to raise $10.85m via a sale of common stock that will be used to support its new BluScience retail brand and for general working capital purposes.
The judge presiding over a high-profile case brought by US vitamin buyers against Chinese firms accused of fixing the price of vitamin C is considering a series of motions filed by the defendants, who claim they were compelled to act as a cartel by the...
A ruling in favor of US vitamin buyers in a high-profile anti-trust case against Chinese firms accused of price fixing could trigger a wave of similar anti-trust cases, experts have predicted.
Fish oil prices will continue to inch up by around 5% a year, according to one omega-3 industry veteran who has just set up a new business selling marine ingredients from the Nordic region to the US.
Direct selling supplements giant Herbalife aims to expand its manufacturing footprint dramatically over the next two-to-four years as it steps up plans to make more of its products in-house.
Dupont, which earlier in the year warned that its May $6.49bn acquisition of Danisco would dent its yearly profits, has defied expectations in second quarter results published today.
The European Commission today approved DuPont’s €4.5bn offer for Danish probiotics, enzymes and ingredients giant Danisco but the deal remains in doubt as to date only 6% of Danisco shareholders have accepted the offer.
It's been on the cards since the fall, and now it's official: Pfizer has agreed to sell hard-capsule manufacturer Capsugel for $2.375 billion in cash to an affiliate of Kohlberg Kravis Roberts & Co L.P. (KKR).
A raft of higher-value products targeting humans rather than animals - from an ultra-potent antioxidant-rich rice bran oil to rice lecithin and food grade defatted rice bran – will help NutraCea puts its troubled past behind it in 2011/12, bosses have...
Royal DSM’s acquisition of Martek Biosciences Corporation has moved a step closer to finalisation with the news that its tender offer to buy all of the company’s outstanding shares of common stock at a price of $31.50 (about €24) per share has proved...
Forty-year-old nutraceutical specialist Stauber Performance Ingredients has been acquired by New York investment firm in a move the company hopes will help it “expand capabilities”.
Rice bran ingredient and nutraceutical supplier NutraCea has emerged from Chapter 11 bankruptcy after just over a year – a move that allowed it to restructure and reduce overheads, the company has said.
Rice bran ingredient supplier NutraCea has said it expects to exit bankruptcy later this year after having filed for Chapter 11 protection in November to allow the company to restructure, reduce overheads and sell non-core assets.
Danone has agreed to acquire liquid protein supplements pioneer Medical Nutrition USA, Inc. (MNI) for $62m, in a move that aims to expand the French company’s US presence in medical nutrition.
Speculation about typical asset valuing ion the chemicals industry by Cognis’s chief financial officer, Marco Panichi, has led to a figure of €3.4bn being attached to the German ingredient company, as buy-out speculation mounts.
ChromaDex is optimistic about its stronghold in the food and supplement sector following a strong first quarter, which saw a revenue increase of 34 percent.
Glanbia Plc is poised to become a more US focused nutrition business with the financial freedom to grow rapidly but Irish farmers could still pull the plug on the deal announced to the media today.
Cargill’s profits more than doubled during its fiscal third quarter as it benefited from the recovering economy across all sectors, particularly in developing countries, the company has said.
After a host of positive moves over the past year, ChromaDex is optimistic about its future business, as it reported a 28 percent sales increase from $4.5m during fiscal 2008 to $5.7m in 2009.
Canadian natural and organics group SunOpta has reported a narrower loss in the fourth quarter of 2009, attributing improvement to restructuring and continued consumer interest in health and wellness.
Cognis has reported a 6.8 per cent decline in nutritional and health product revenue for the first 9 months of 2009 as the European market weakens and supplement sales slump.
Naturex president and chief executive officer, Jacques Dikansky, tells Shane Starling why in August the French botanicals giant bought Spanish supplier, Natraceutical Group, to double its size for the third time since 2002.
The economic recession is biting across the globe, and bleeding casualties litter all industries, but now is not the time to cower. Those willing to spend may provoke a stimulation of their business that could set them up for years, if not decades, to...
Supplements and healthy foods are proving to be more resilient than other sectors in the midst of the current economic freeze. Investment banker David Thibodeau tells Lorraine Heller why this sector will continue to perform.
Omega-3 supplier Martek Biosciences has reported a strong performance in the first quarter, indicating a growing interest in DHA despite the tight economy.
Cyanotech, which produces nutritional ingredients from microalgae, has said its focus on increased productivity and cost containment has helped reverse its loss from last year’s third quarter.
Swedish probiotics specialist, BioGaia, has turned in an impressive set of financial results for 2008, maintaining the 30 per cent-plus growth it has achieved annually for the best part of this decade.
Microalgae supplier Cyanotech said an increased productivity for spirulina and astaxanthin have helped lift its business out of loss in the second quarter.
Lipid Nutrition has signed an agreement to make ChemPoint the exclusive distributor of its weight management ingredients to the North American dietary supplement market.
DSM has turned in a healthy third quarter, with its nutrition division seemingly unaffected by the financial meltdown and demonstrating “sustained strong profitability”.
